Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease.
第一作者:
Faizan,Faizee
第一单位:
Pulmonary Disease and Critical Care Medicine, Corewell Health East, Royal Oak, MI, 48073, USA. Faizee.faizy@gmail.com.;Corewell Health East, William Beaumont University Hospital, Royal Oak, MI, 48073, USA. Faizee.faizy@gmail.com.
作者:
医学主题词
人类(Humans);男(雄)性(Male);女(雌)性(Female);代谢组学(Metabolomics);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);老年人(Aged);中年人(Middle Aged);前瞻性研究(Prospective Studies);脂类代谢(Lipid Metabolism);肺疾病, 间质性(Lung Diseases, Interstitial);代谢组(Metabolome);疾病恶化(Disease Progression);脂类(Lipids);色谱法, 液相(Chromatography, Liquid)
DOI
10.1007/s11306-025-02355-8
PMID
41139176
发布时间
2025-11-29
- 浏览0
Metabolomics
153页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



